Die Vermeidung von Pflegekosten bei der Alzheimer-Erkrankung durch Galantamin

verfasst von

S. Braun, W. Greiner, J. M. Von Der Schulenburg

Abstract

Aim. The aim of this paper is to systematically review health-economic evidence for treating Alzheimer's disease with galantamine. Methods. First, a structured literature search of relevant databases was conducted. In a second step, all hits were screened for their content and were evaluated separately by two different researchers. Subsequently, a structured review of all relevant papers was prepared. Results. Of the initial 197 search results, eight health-economic studies were found to methodologically and thematically match with the study question. The results of all evaluated studies suggest an economic efficiency for treating Alzheimer's disease with galantamine, although all studies face certain limitations; most of the underlying models made specific assumptions, resulting in additional uncertainty around the respective results. Conclusion. Despite ongoing medical research in this area, galantamine, as compared with no drug therapy, can be considered an economically reasonable treatment alternative within the German health care system. Additional studies evaluating some of the models' assumptions must be conducted in the future to further support these findings.

Organisationseinheit(en)

Institut für Gesundheitsökonomie

Externe Organisation(en)

Universität Bielefeld

Typ

Artikel

Journal

Pravention und Gesundheitsforderung

Band

3

Seiten

145-151

Anzahl der Seiten

7

ISSN

1861-6755

Publikationsdatum

08.2008

Publikationsstatus

Veröffentlicht

Peer-reviewed

Ja

ASJC Scopus Sachgebiete

Öffentliche Gesundheit, Umwelt- und Arbeitsmedizin

Ziele für nachhaltige Entwicklung

SDG 3 – Gute Gesundheit und Wohlergehen

Elektronische Version(en)

https://doi.org/10.1007/s11553-008-0121-5 (Zugang: Geschlossen)